Max Financial Services Ltd
NSE: MFSL BSE: 500271
₹1625.40
(0.46%)
Sun, 24 May 2026, 04:38 pm
Market Cap558.43B
PE Ratio579.49
Dividend0
Finance
Life/Health Insurance
24.5KCompany History
1988
- Incorporated February 24; commenced business March 21; manufactured BOPP films; promoted by Max India Ltd., Ranbaxy Laboratories Ltd., Montari Industries Ltd., PSIDC.
- Planned 2,000 tonnes BOPP film project.
- Organized business into Max Pharma, Max Electronics, Maxxon BOPP Films, Max Telecom post-amalgamation.
- Formed Max-GB Ltd. 50:50 JV with Gist-Brocades for Penicillin-based intermediates and bulk drugs.
- Planned bulk drugs facility at Nanjangud, Karnataka.
1989
- Issued 1,450,000 12% secured convertible debentures; all taken up.
- Converted Part-A into 2,900,000 equity shares.
1991
- Max India expanded into pharmaceutical formulations at Okhla, New Delhi.
- Introduced Maxmox, Cefamax, Floxip, Rejoor.
1992
- Set up Hutchison Max Telecom Pvt. Ltd. JV with Hutchison Telecom for value-added services.
- Entered JV understanding with Comsat USA for VSAT services.
1993
- Merged with Max India effective January 1; retained Max India Ltd. name.
- Allotted equity shares post-merger: 580,000 to debenture trustees, 75,000 to associate, 742,750 and 62,39,450 to shareholders, 70 to promoters; issued 45,27,430 shares.
1994
- Introduced Maxfoil for leather industry.
- Commissioned cellular, paging, VSAT networks.
- Launched Max torch cellular in Mumbai; paging in Bangalore, Hyderabad, Baroda, Ahmedabad, Pune, Ludhiana, Chandigarh.
- Planned design center for exports.
- Proposed 600,000 warrants to management at Rs 383.75 per share.
- Proposed Rs 152 cr zero coupon FCDs and NCDs with warrants on rights.
1995
- Hutchison Max Telecom commenced paging in multiple cities; cellular in Mumbai.
- Launched Max foil at Railmajra facility.
- Inaugurated JV with Hindustan Antibiotics for Penicillin G.
- JV to launch six products including Depo-Provera; agreement with Pierre Fabre.
- Paging service launched in all licensed cities.
- Commissioned VSAT master earth station; entered banking, financial sectors.
- Issued 833,720 zero coupon FCDs on rights; allotted 823,720 shares on Part A conversion.
- Issued 1,647,440 12.5% NCDs with warrants on rights.
- Allotted 1,423,720 shares on warrant conversion.
1996
- Launched Upjohn products from new sterile facility.
- Exclusive representative of Motorola Semi Conductor for south India.
- Set up group for turnkey PCB plants.
- Formed JV with Atotech BV for PCB plating chemicals.
- Commissioned films metallising plant; launched Maxmet metallised BOPP films.
2000
- Approved 1:1 bonus issue, ESOP, and increased authorised capital.
- Acquired majority interest in HealthScribe India Pvt. Ltd.
- Divided business into Healthcare, Financial Services, IT, Pharmaceuticals, Speciality Products, Telecom.
- Sold 24% stake in Max GB to DSM for Rs. 26 cr.
- Appointed Kanti Mohan Rustagi as C.S. from August 9.
- Analjit Singh appointed Chairman; split MD posts for IT and healthcare.
- Jagdish Anand resigned; Nripjit Singh Chawla appointed MD from October 3.
2001
- Max Healthcare opened two primary (Dr Max) and one secondary (Max Medcentre) centres in New Delhi.
- Max New York Life to enter bancassurance.
2002
- Became first private player interested in health insurance.
- Board approved spin-off of healthcare division to wholly owned subsidiary.
- Approved divestment of 5% in DSM-Anti Infectives India to JV partner.
- Released 'Host-Protect-Delivery-Manage' suite.
- Shareholders approved sale of healthcare division to subsidiary.
- Max Healthcare recast as Max Healthcare Institute Ltd.
- Extended clinics to schools and corporate offices.
- Board approved disinvestment of 40% in Avnet Max.
- Board approved sale of pharmaceutical division to Jubilant Organosys for Rs. 62.7 cr.
2003
- Board approved acquisition of 49% equity in Cosmat Max for US $750,000.
- Board approved investment up to Rs. 55 million in Max Healthstaff International Ltd.
- Closed Max Ateev and Alta Cast, incurring Rs. 65 cr loss.
- Shareholders approved delisting from ASE, CSE, DSE, LSE.
2004
- Surendra Kaul to leave as Whole-time Director by November 30.
- Warburg Pincus entered strategic partnership with Max India.
- Warburg Pincus partnered with Max Healthcare.
2005
- Max Telecom Ventures to divest stake in Hutchison Essar Telecom.
- Max Telecom Ventures signed MoU.
2007
- Appointed Anuroop Singh as Additional Director.
- Split face value from Rs. 10 to Rs. 2.
2008
- Signed agreement with UK firm for health insurance business.
2010
- Rolled out health insurance JV with Bupa.
2011
- Appointed Vishal Bakshi as Alternate Director to Sanjeev Mehra.
- Max India acquired Max Healthcare Institute Limited.
2012
- Investors approved promoters' stake hike.
- Appointed Professor Dipankar Gupta as Non-Executive Independent Director.
- Reports of MS&AD buying 26% in Max India-New York Life JV.
2013
- Board declared interim dividend of 90% (Rs. 1.80 per Rs. 2 share).
- Boston University conferred 'Distinguished Alumni' award to Analjit Singh.
2014
- Max Bupa won technology award at India Insurance Awards.
- Standard Chartered Bank entered bancassurance tie-up with Max Bupa.
- Max Bupa introduced comprehensive family health insurance plan.
- Board recommended final dividend of 90% (Rs. 1.80 per Rs. 2 share).
2015
- Approved splitting company into three entities.
- Punjab and Haryana High Court approved Scheme of Arrangement.
2016
- Max India Ltd. name changed to Max Financial Services Ltd.; symbol changed to MFSL.
2017
- Service Category improvement Award for Six Sigma project 'Reducing 7 day POS TAT'.
- Max Life Insurance won Best Big Data/Analytics Team of the Year Award.
- Max Life received 'Most Admired Brand' award.
- Max Life IT won 'IT Genius Award'.
2018
- Max Financial bought additional stake in insurance arm for Rs 153 cr.
- New York Life picked up 2% stake in Max Financial Services for Rs 2.15 bn.
2020
- IRDAI approved swap of Mitsui Sumitomo's Max Life stake with Max Financial Services.
- Max Financial Services settled tax dispute under Vivad Se Vishwas Scheme.
- Max Life became 70:30 joint venture between Max Financial Services and Axis Bank.
- Max Group launched initiative for one lakh Social Isolation pledges.
- Axis Bank to explore long-term strategic partnership with Max Life.
2021
- Axis Bank became co-promoter of Max Life.
2022
- Max Financial Services Limited completed acquisition of balance 5.17% stake in Max Life from MSI, Japan.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Asset Management Companies
Popular Stocks
Indian Indices
Sector Wise Stocks
IPO
Share Market
Best MF Schemes
Platforms
Resources
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800